Literature DB >> 2526301

Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.

E Gottberg1, L Diop, B Montreuil, T A Reader.   

Abstract

The effects of sodium, lithium, and magnesium on the in vitro binding properties of the D1 antagonist [3H]SCH23390 were examined with membrane preparations from rat neostriatum (CPU; caudate-putamen) and cerebral cortex (CTX). The saturation binding isotherms for both tissues performed in the presence of 120 mM of either Na+ or Li+ revealed an increase in the affinity, as compared to that observed when the incubation buffer was composed of Tris-Cl 50 mM with MgCl2 1 mM alone. For the CPU there were no changes in the maximum binding capacity (Bmax) in the different buffers used. In the case of the CTX, there was a loss of [3H]SCH23390 binding sites when either Na+ or Li+ 120 mM were added to the incubations, suggesting a lack of selectivity of this ligand in the absence of group IA cations. The agonist state of the [3H]SCH23390 binding site was studied in competition experiments with dopamine. The highest agonist affinity was obtained in 50 mM Tris-Cl buffer with 1 mM MgCl2 while the addition of 120 mM of either Na+ or Li+ caused a 3- to 5-fold decrease in the potency of dopamine to compete with specific [3H]SCH23390 binding in both CPU and CTX. The presence of magnesium was essential for the competition experiments; i.e.: a concentration of 1 mM MgCl2 was optimum to obtain dopamine antagonism of ligand binding, while increasing Mg2+ to 2 or 5 mM did not appear to further improve the inhibitions. The results support both agonist and antagonist affinity shifts for the dopamine D1 receptor labeled with [3H]SCH23390.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526301     DOI: 10.1007/bf00964855

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

1.  Acute effects of lithium on dopaminergic responses: iontophoretic studies in the rat visual cortex.

Authors:  E Gottberg; B Montreuil; T A Reader
Journal:  Synapse       Date:  1988       Impact factor: 2.562

2.  SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity.

Authors:  T Skarsfeldt; J J Larsen
Journal:  Eur J Pharmacol       Date:  1988-04-13       Impact factor: 4.432

Review 3.  Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.

Authors:  J L Waddington
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

4.  The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.

Authors:  S Bischoff; M Heinrich; J M Sonntag; J Krauss
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

5.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

6.  Conversion of dopamine D1 receptors from high to low affinity for dopamine.

Authors:  P Seeman; C Ulpian; D Grigoriadis; I Pri-Bar; O Buchman
Journal:  Biochem Pharmacol       Date:  1985-01-01       Impact factor: 5.858

7.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.

Authors:  S J Boyson; P McGonigle; P B Molinoff
Journal:  J Neurosci       Date:  1986-11       Impact factor: 6.167

9.  Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.

Authors:  M H Makman; B Dvorkin
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

10.  Effect of lithium and sodium ions on opiate- and dopamine-receptor binding.

Authors:  I J Wajda; M Banay-Schwartz; I Manigault; A Lajtha
Journal:  Neurochem Res       Date:  1981-03       Impact factor: 3.996

View more
  4 in total

1.  Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity.

Authors:  T A Reader; L Grondin; B Montreuil; K M Dewar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

2.  Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.

Authors:  T A Reader; E Molina-Holgado; K M Dewar
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

3.  Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

4.  Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.